Miltenyi Biotec Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Miltenyi Biotec Gmbh

Patent Number:
Title:
Use Of Chimeric Antigen Receptor-Modified T Cells To Treat Cancer
Opposition Date:
Jul 2, 2019
Patent Number:
Title:
Scalable Lentiviral Vector Production System Compatible With Industrial Pharmaceutical Applications
Applicant:
Opposition Date:
Oct 9, 2018

Latest patents of Miltenyi Biotec Gmbh opposed by its competitors

Patent:
Grant Date:
Jan 2, 2019
Title:
Method For Automated Generation Of Genetically Modified T Cells
Oppositions:
3
Patent:
Grant Date:
Sep 26, 2018
Title:
Combination Immunotherapy Of Antigen-Recognizing Receptors And Hematopoietic Cells For The Treatment Of Diseases
Oppositions:
1

Want to track Miltenyi Biotec Gmbh?

Feel free to send us a message here and we will get back to you